CDK Global, Inc. is a company in the U.S. stock market and it is a holding in 114 U.S.-traded ETFs. CDK has around 14.0M shares in the U.S. ETF market. The largest ETF holder of CDK is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 3.33M shares. Investors may also find of interest that the ETF with the largest allocation to CDK stock is ProShares Merger ETF (MRGR), with a portfolio weight of 2.42%. On average, U.S. ETFs allocate 0.25% of CDK to their portfolios.
Additionally, CDK is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CDK as a holding is the AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL), with a return of 16.53%.